Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2/3 Multicenter Study Evaluating the PRV Platform of Localized Nanoengineered Therapies for Oral Cavity and Lung Cancers

NCT05893888 is registered in ClinicalTrials.gov with Privo Technologies as lead sponsor.

NCT NCT05893888
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05893888 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2/3 Multicenter Study Evaluating the PRV Platform of Localized Nanoengineered Therapies for Oral Cavity and Lung Cancers
Lead sponsor
Privo Technologies
Phase
Phase 2/3
Overall status
Recruiting
Start date
November 7, 2024
Completion date
May 31, 2027
Enrollment
40 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

oral squamous cell carcinoma